Company Filing History:
Years Active: 2022-2024
Title: Jackie Marks: Innovator in Zika Vaccine Development
Introduction
Jackie Marks is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of vaccine development. With a total of 5 patents to his name, Marks has focused his research on innovative solutions to combat viral infections, particularly the Zika virus.
Latest Patents
Among his latest patents, Marks has developed Zika vaccines and immunogenic compositions. These patents relate to vaccines and immunogenic compositions that contain one or more antigens from the Zika virus, including clonal isolates and non-human cell-adapted strains. The methods of treatment and uses of these vaccines are crucial in addressing the public health challenges posed by the Zika virus.
Career Highlights
Jackie Marks is currently associated with Takeda Vaccines, Inc., where he continues to advance his research in vaccine technology. His work has been instrumental in the development of effective immunization strategies against the Zika virus, contributing to the broader field of infectious disease prevention.
Collaborations
Marks collaborates with several talented individuals in his field, including Jill Ann Livengood and Hansi Dean. These partnerships enhance the innovative potential of his research and contribute to the success of his projects.
Conclusion
Jackie Marks stands out as a key figure in the development of Zika vaccines, with a strong portfolio of patents that reflect his commitment to public health. His work at Takeda Vaccines, Inc. continues to pave the way for advancements in vaccine technology.